Recherche avancée

Actuellement, Jeremiah Alphonsus O'Callaghan est président du conseil d'administration de JBS SA, co-directeur de JBS Investments II GmbH et responsable des relations avec les investisseurs de JBS Foods International (toutes deux filiales de JBS SA). Il est également membre du conseil d'administration de JBS Investments UK Ltd. Il a obtenu un diplôme de premier cycle à l'University College Cork.

Jeremiah Brazeau est actuellement directeur de la technologie chez Twilio, Inc. Il a précédemment occupé le poste de vice-président senior et d'architecte distingué chez salesforce.com, inc. Il a obtenu un diplôme de premier cycle et un diplôme d'études supérieures de l'Institut de technologie de Rochester et un diplôme d'études supérieures de l'Université de Northeastern.

Barbara S. Jeremiah est présidente désignée de The Weir Group Plc. Elle est également membre de l'Université de Virginie et siège au conseil d'administration de 6 autres sociétés. Dans le passé, elle a occupé le poste de présidente de Boart Longyear Ltd, de vice-présidente exécutive d'Alcoa Corp. et de vice-présidente exécutive chargée du développement de l'entreprise chez Alcoa, Inc. Elle est titulaire d'un diplôme de premier cycle de l'université Brown et d'un diplôme d'études supérieures de la faculté de droit de l'université de Virginie.

Alphonsus Moniz worked as a Portfolio Manager at P.
Schoenfeld Asset Management LP from 2017 to 2019 and as a Partner & Portfolio Manager at Fore Research & Management LP from 2003 to 2017.
He holds a graduate degree from Boston College, an MBA from Cochin University of Science & Technology, and an undergraduate degree from Visvesvaraya College of Engineering.

Alphonsus Chua is currently the Managing Director at GB Chemicals Pte Ltd.
where he has been working since 1996.
Prior to this, he was the Managing Director at AP Oil International Ltd.

Alphonsus Richard Monteiro has worked as a Director at Plant-Tech Industrial Services Ltd.
since 2000.

Alphonsus Chia currently works at Digiassets Exchange (Singapore) Pte Ltd., as Chief Commercial & Partnership Officer.

Anton Bernard Alphonsus worked as a Secretary & Director at First City Care (London) Ltd.
from 2012 to 2017.
He also worked as a Secretary & Director at Spector Lumenex Ltd.

Mr. Shea O’Callaghan is a Research Associate at Mackie Research Capital Corp.

Lasair O'Callaghan worked as the Head of Business Development at CHG Management Services Ltd.

Caroline Jaqueline Michele O'Callaghan worked as an Investment Director at Rathbones Investment Management Ltd.
from 2012 to 2016.

James C.
O’Callaghan is currently a Managing Director at Growth Catalyst Partners LLC.
Prior to his current position, he served on the Board of Directors for Journey Holdings Ltd., The Stable Group LLC, Trendline Interactive LLC, and Beachfront Media LLC.
From 2014 to 2017, he worked as a principal at Emil Capital Partners LLC.
From 2010 to 2014, he was a Senior Associate at The Jordan Edmiston Group, Inc. He also held a position as a Principal at GE Capital Financial, Inc. Mr. O’Callaghan obtained his undergraduate degree from Kelley School of Business.

Michael O'Callaghan is an economist who currently works at The Economic & Social Research Institute.

Mr. O’Callaghan founded CPI, a pioneer in the recruiting industry, in 1996.
He has been fortunate to work with successful investment firms and their portfolio companies, helping them hire talent and manage the intricacies of managing, empowering and inspiring teams.
Brian has been involved with several entrepreneurial ventures acting as a founder, investor and advisor including, most recently, the Autism Impact Fund.
CPI is 41 people in 4 cities working closely together to provide clients access to talent through our extraordinary network, while sharing useful information and counsel.
DEI hiring and retention is a Firm-wide passion that we focus on every day.
Brian manages CPI and helps execute projects at all levels.
With the support and leadership of his talented colleagues, Brian has helped nurture a close, collaborative and entrepreneurial culture.
The team works selflessly together, sharing the brain share and resources of the Firm with clients.
Prior to founding CPI, Brian was a Vice President with Jones Lang LaSalle and an Analyst with Morgan Stanley in the Investment Banking Real Estate Group.
Brian is a graduate of The Lawrenceville School and Denison University.
He is a member of the Board of Berkshire School and King School.

Lawrence R.
O’Callaghan is currently a Director at Missouri Valley REIT, Inc. He was previously a Trustee at Sterling Real Estate Trust from 2003 to 2013.

Scott O'Callaghan is an Independent Director at North Mountain Merger Corp.
He previously worked as a Managing Director at MidOcean US Advisor LP from 2009 to 2010, and as an Independent Director at South Mountain Merger Corp.
from 2020 to 2021.
He also held Principal positions at Drexel Burnham Lambert Real Estate Associates II, Deutsche Bank Investment Management, Inc., and Bankers Trust & Co. Additionally, he was Head-Leveraged Sales at Bank of America Corp.
in 2009.
O'Callaghan received his undergraduate degree from Brown University in 1986.

Matt E.
O'Callaghan worked as an Analyst at Mariner Investment Group LLC from 2000 to 2002.
He also worked as an Analyst at Pirate Capital LLC.
Later, he worked as a Senior Bank Loan Trader at Odeon Capital Group LLC from 2011 to 2015.
O'Callaghan received his undergraduate degree from the University of St. Thomas in 1999.

Brian O'Callaghan was the founder and had founded Biopartners GmbH in 2000, where he served as the President & Chief Executive Officer until 2004.
He is currently the Chief Executive Officer & Director at Deep Genomics, Inc. since 2023, Director at BIOCOM since 2013, Director at Century Club of San Diego, Independent Director at Bolt Biotherapeutics, Inc. since 2021, and Director at Petra Pharma Corp.
since 2017.
Mr. O'Callaghan has held former positions as the President, Chief Executive Officer & Director at Sangart, Inc. from 2008 to 2014, President, Chief Executive Officer & Director at Acucela, Inc. in 2013, Chief Executive Officer at Sonrgy, Inc. from 2015 to 2017, Chief Commercial Officer at NPS Pharmaceuticals, Inc. from 2007 to 2008, General Manager at Labcorp Drug Development, Inc., General Manager at Merck KGaA, GM-North American Transplantation & Immunology at Novartis Pharmaceuticals Corp.
from 2004 to 2006, and Chief Executive & Financial Officer at Kubota Pharmaceutical Holdings Co. Ltd.
Mr. O'Callaghan also served as a Director at Aquavit Pharmaceuticals, Inc., Intec Pharma Ltd., ObsEva SA from 2020 to 2023, and Decoy Biosystems, Inc., as well as an Independent Director at Indaptus Therapeutics, Inc. He holds an MBA from The HENLEY College.

Mr. Shannon O'Callaghan is an Analyst at UBS Securities LLC.
Mr. O'Callaghan was previously employed as a Managing Director by Nomura Securities International, Inc., an Analyst by Credit Agricole Securities (USA), Inc., Barclays Capital, Inc., and a Lehman Brothers, Inc. He received his undergraduate degree from Boston College, a graduate degree from Boston College and an MBA from Massachusetts Institute of Technology.

John F.
O’Callaghan is currently the EVP, Global Head-Field Marketing & Operations at Triton International Ltd.
Prior to this, he worked at Triton Container International Ltd.
for 22 years, where his last position was Senior VP-Europe & North America Subcontinent.
He obtained his undergraduate degree from Trinity College Dublin.

Michael O'Callaghan is currently a member of the Governors Board at the Business Council of British Columbia.

Bernie O'Callaghan has worked as a Board Member & Representative for Athletics Ireland and is currently employed by Athletics Northern Ireland as a Board Member & Representative.